Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

UCB-0599 shows safety in older individuals with PD with age-related comorbidities

April 22, 2021

AUT-00206 improves auditory information processing in patients with schizophrenia

April 22, 2021

FDA clears IND application for APB-102 as treatment of SOD1 ALS

April 22, 2021

AP-101 appears to be safe and well tolerated in phase I study in ALS patients

April 22, 2021

King's College London presents adeno-associated viral vectors

April 21, 2021

Pivotal study evaluates ION-373 for Alexander disease

April 21, 2021

SEP-363856 is associated with robust improvement in negative symptoms of schizophrenia

April 21, 2021

European Commission approves Epidyolex for tuberous sclerosis complex

April 20, 2021

Brain injury modulates bone marrow cells to reduce neuroinflammation

April 19, 2021

Autotaxin inhibitor BIO-32546 for neuropathic pain

April 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...